Concepedia

Patrick DeRoy

PD

Statistics

Publications

14

Citations

746

H-Index

13

Active since

2003

Affiliations

Boehringer Ingelheim (Canada)(Current)

Paraza Pharma (Canada)

Boehringer Ingelheim (Egypt)

Université Laval

University of California, Los Angeles

Patrick DeRoy is an author at Boehringer Ingelheim (Canada) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

2003–2024

14

Publications

14

Electrolytic Macrocyclizations: Scalable Synthesis of a Diazonamide‐Based Drug Development Candidate

Hui Ding, Patrick DeRoy, Christian Perreault et al. · Angewandte Chemie International Edition · 2015 · 135 citations

, , +14

Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly

Lee D. Fader, Richard C. Bethell, Pierre Bonneau et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 104 citations

, , +12

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency

Pierre L. Beaulieu, Michael Bös, Yves Bousquet et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 90 citations · Full text

, , +15

Selective inhibition of CDK7 reveals high-confidence targets and new models for TFIIH function in transcription

Jenna K. Rimel, Zachary C. Poss, Benjamin Erickson et al. · Genes & Development · 2020 · 87 citations · Full text

, , +16

Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases

Alexandre Gagnon, Ma’an Amad, Pierre Bonneau et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 53 citations · Full text

, , +17

1–5 of 14